The current global guideline recommendations for postnatal antiretroviral prophylaxis in vertical HIV transmission are discussed in this interview with Dr Martina Penazzato (World Health Organization (WHO), Geneva, Switzerland). Dr Penazzato also discusses new strategies currently under investigation to reduce HIV transmission, and the challenges that still remain in translating developments in HIV transmission to a paediatric setting.
The talk entitled: ‘Antiretrovirals for prevention: from adults to babies’ was presented at Conference on Retroviruses and Opportunistic Infections (CROI) 2022 (Virtual), 12-16 February 2022.
- Postnatal antiretroviral prophylaxis (PNP) is important for preventing vertical HIV transmission – what are the current global guideline recommendations for PNP? (0:32)
- What challenges have there been in implementing guideline recommendations? (2:32)
- Please outline what new strategies are currently under investigation to reduce HIV transmission? (4:58)
- What challenges remain in translating developments in HIV transmission to a paediatric setting, and how can these be overcome? (7:58)
- What impact would decreasing vertical HIV transmission have on patients and society at large? (10:11)
Disclosures: Martina Penazzato has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of CROI 2022
Share this Video
Related Videos In HIV
Updated HIV primary care guidelines: Mamta Jain, ACTHIV 2023
Updated HIV primary care guidelines provide evidence-based and standardized approaches to manage individuals living with HIV, addressing their unique needs and challenges. By following these guidelines, healthcare providers can enhance patient outcomes and stay abreast of the latest research and treatment advancements in HIV care. In this interview, we speak with Dr Mamta Jain (UT […]
Managing liver complications and drug-drug interactions in HBV-HIV co-infection: ACTHIV 2023 with Jessie Torgersen
Liver complications and drug-drug interactions in HBV viremia in HIV patients are common, so it is important to consider complications and follow appropriate guidelines for patients when prescribing treatment. In this interview, we speak with Dr Jessie Torgersen (University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA) to explore considerations for healthcare professionals, including liver complications […]
HIV-HBV co-infection screening and monitoring guidelines: ACTHIV 2023, Jessie Torgersen
Screening and managing HIV-hepatitis B virus (HBV) co-infection is important due to increased risks in patients, therefore it is important to ensure standard practices involve comprehensive assessment, including serological testing and liver function evaluation, and healthcare professionals follow guidelines for regular monitoring to assess disease progression and treatment response. In this interview, we speak with […]